financetom
Business
financetom
/
Business
/
Occidental Petroleum Unusual Options Activity For September 20
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Occidental Petroleum Unusual Options Activity For September 20
Sep 20, 2024 9:03 AM

Whales with a lot of money to spend have taken a noticeably bullish stance on Occidental Petroleum ( OXY ).

Looking at options history for Occidental Petroleum ( OXY ) we detected 9 trades.

If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish expectations and 44% with bearish.

From the overall spotted trades, 2 are puts, for a total amount of $203,760 and 7, calls, for a total amount of $659,920.

Predicted Price Range

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $40.0 to $65.0 for Occidental Petroleum ( OXY ) over the last 3 months.

Analyzing Volume & Open Interest

Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Occidental Petroleum's ( OXY ) options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Occidental Petroleum's ( OXY ) significant trades, within a strike price range of $40.0 to $65.0, over the past month.

Occidental Petroleum 30-Day Option Volume & Interest Snapshot

Significant Options Trades Detected:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
OXY CALL SWEEP NEUTRAL 09/19/25 $1.9 $1.8 $1.8 $65.00 $179.8K 73 581
OXY PUT SWEEP BEARISH 12/20/24 $4.8 $4.75 $4.8 $55.00 $142.5K 14.0K 6
OXY CALL TRADE BULLISH 12/20/24 $2.7 $2.7 $2.7 $52.50 $135.0K 1.6K 0
OXY CALL TRADE BEARISH 01/16/26 $5.85 $5.7 $5.7 $55.00 $114.0K 1.2K 203
OXY CALL SWEEP BEARISH 10/18/24 $0.98 $0.96 $0.96 $52.50 $96.1K 9.5K 1.5K

About Occidental Petroleum

Occidental Petroleum ( OXY ) is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2023, the company reported net proved reserves of nearly 4 billion barrels of oil equivalent. Net production averaged 1,234 thousand barrels of oil equivalent per day in 2023 at a ratio of roughly 50% oil and natural gas liquids and 50% natural gas.

Following our analysis of the options activities associated with Occidental Petroleum ( OXY ), we pivot to a closer look at the company's own performance.

Present Market Standing of Occidental Petroleum

Trading volume stands at 4,072,063, with OXY's price down by -1.49%, positioned at $51.26.

RSI indicators show the stock to be may be oversold.

Earnings announcement expected in 46 days.

Expert Opinions on Occidental Petroleum

Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $69.66666666666667.

Unusual Options Activity Detected: Smart Money on the Move

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.

* An analyst from UBS persists with their Neutral rating on Occidental Petroleum ( OXY ), maintaining a target price of $59.

* Maintaining their stance, an analyst from Susquehanna continues to hold a Positive rating for Occidental Petroleum ( OXY ), targeting a price of $78.

* Consistent in their evaluation, an analyst from Mizuho keeps a Neutral rating on Occidental Petroleum ( OXY ) with a target price of $72.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Occidental Petroleum ( OXY ) options trades with real-time alerts from Benzinga Pro.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Group 1 Automotive Boosts Credit Facility to $3.5 Billion, Extends Maturity to 2030
Group 1 Automotive Boosts Credit Facility to $3.5 Billion, Extends Maturity to 2030
May 30, 2025
01:09 PM EDT, 05/30/2025 (MT Newswires) -- Group 1 Automotive ( GPI ) increased its revolving credit facility by $1 billion to $3.5 billion and extended the maturity to May 30, 2030. The facility can be expanded to $4.5 billion, subject to approval from 18 lenders, including six manufacturer-affiliated finance companies and 12 commercial banks, Group 1 said Friday in...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Sector Update: Consumer
Sector Update: Consumer
May 30, 2025
01:06 PM EDT, 05/30/2025 (MT Newswires) -- Consumer stocks were mixed Friday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) increasing 0.8% and the Consumer Discretionary Select Sector SPDR Fund (XLY) falling 1%. In corporate news, Costco Wholesale ( COST ) reported fiscal Q3 earnings and revenue above market estimates, but the warehouse chain's comparable sales fell short...
Cartesian Therapeutics Enrolls First Participant in Phase 3 Myasthenia Gravis Study
Cartesian Therapeutics Enrolls First Participant in Phase 3 Myasthenia Gravis Study
May 30, 2025
01:02 PM EDT, 05/30/2025 (MT Newswires) -- Cartesian Therapeutics ( RNAC ) said Friday it enrolled the first participant in its phase 3 myasthenia gravis study that will evaluate Descartes-08, the company's lead cell therapy candidate for autoimmune disease. The study will evaluate Descartes-08 versus placebo given as six once-weekly outpatient infusions without preconditioning chemotherapy in about 100 participants who...
Copyright 2023-2026 - www.financetom.com All Rights Reserved